Verisys

DECEMBER 12, 2023

– The best resource for monthly healthcare regulatory compliance updates. US S3193 DEA: The DEA and Department of Health and Human Services (HHS) has announced the extension of current telemedicine flexibilities through December 31, 2024. This bill is currently in committee.

Regulatory Compliance 52

Regulatory Compliance Compliance US Department of Health and Human Services Licensing 52

Exeed Regulatory Compliance

JULY 31, 2020

How Emergency Use Authorization of Medical Products Helps Provide Relief During a COVID-19 Major Crisis. It is a public health emergency of massive scale that has affected nearly all aspects of our life. The current COVID-19 global pandemic continues to remain out of control.

FDA 52

FDA COVID-19 US Department of Health and Human Services Public Health 52

Exeed Regulatory Compliance

MARCH 5, 2020

Secretary of the Department of Health and Human Services (HHS) has declared a public health emergency. The World Health Organization (WHO) has stopped short of classifying the outbreak as a pandemic, but consistently encouraged affected countries to activate their national emergency response plans.

US Department of Health and Human Services 52

US Department of Health and Human Services FDA Public Health COVID-19 52

SQA

OCTOBER 18, 2022

SQA Regulatory Surveillance Summary for July and August 2022. Health Canada. Health Canada is warning consumers about counterfeit BTNX Rapid Response COVID-19 antigen rapid test kits (25-pack boxes) found in Ontario. products in color and typeface and uses the BTNX Inc. and one distributor, Healthful Plus.

US Department of Health and Human Services 40

US Department of Health and Human Services FDA COVID-19 Compliance 40

Drug & Device Law

DECEMBER 29, 2023

Executive Health Resources, Inc. , Executive Health Resources, Inc. , United States Department of Health and Human Services , 58 F.4th In 2023, these include United States ex rel. Polansky v. UnitedHealthcare, Inc. , 3d 239 (Cal. Croda Inc. , 3d 191 (Del. C-8 Personal Injury Litigation , 87 F.4th

FDA 105

FDA US Department of Health and Human Services COVID-19 Informed Consent 105